Search
for

    Sort by

    Research 30 of 1000+

    1. An assessment of (1) cyproterone acetate and (2) ethinyl oestradiol and lynoestrenol (Minilyn) in the treatment of idiopathic hirsutism 1978 · 8 citations
    2. Systemic cyproterone acetate and 5% minoxidil topical in the treatment of female pattern hair loss Journal of Pakistan Association of Dermatology · 2016
    3. Relapse of hirsutism following long‐term successful treatment with oestrogen–progestogen combination Clinical endocrinology · 2000 · 22 citations
    4. Treatment of hyperandrogenic alopecia in women Fertility and Sterility · 2003 · 108 citations
    5. [Analysis of steroids and binding proteins in the blood of women with androgenetic alopecia]. PubMed · 1994
    6. Profile of the progesterone derivative chlormadinone acetate — Pharmocodynamic properties and therapeutic applications Contraception · 2009 · 33 citations
    7. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women Human Reproduction Update · 2017 · 117 citations
    8. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss Dermatologic Therapy · 2018 · 13 citations
    9. The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases Advances in Urology · 2011 · 218 citations
    10. Management of Hair Loss Dermatologic Clinics · 2005 · 74 citations
    11. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara®) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial Contraception · 2009 · 42 citations
    12. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review The European Journal of Contraception & Reproductive Health Care · 2017 · 11 citations
    13. Female Pattern Hair Loss international journal of endocrinology and metabolism · 2013 · 57 citations
    14. PCOS and Obesity: Contraception Challenges Open Access Journal of Contraception · 2025 · 4 citations
    15. Health and fertility in World Health Organization group 2 anovulatory women Human Reproduction Update · 2012 · 88 citations
    16. Management OF Patients with Polycystic Ovary Syndrom Neliti · 2025
    17. Polycystic ovary syndrome Nature Reviews Disease Primers · 2016 · 883 citations
    18. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. PubMed · 2002 · 74 citations
    19. Polycystic ovary syndrome Journal Of Endocrinology, Metabolism And Diabetes Of South Africa · 2009 · 9 citations
    20. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism Journal of Steroid Biochemistry · 1975 · 232 citations
    21. Pharmacologic Modulation of Sebaceous Gland Activity: Mechanisms and Clinical Applications Dermatologic Clinics · 2007 · 30 citations
    22. Polycystic ovary syndrome Medicine · 2017 · 4 citations
    23. PHARMACOVIGILANCE STUDY OF SIDE EFFECTS ASSOCIATED WITH LEVONORGESTROL -ETHINYL ESTRADIOL AND DEPOTMEDROXY PROGESTERONE ACETATE 2024
    24. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review Dermatology and Therapy · 2023
    25. Sex hormones and related compounds, including hormonal contraceptives Side effects of drugs annual · 2014
    26. Alopecia - the search for novel agents continues Expert Opinion on Therapeutic Patents · 1997 · 11 citations
    27. Updates on Hirsutism: A Narrative Review International Journal of Biomedicine · 2022 · 2 citations
    28. [Cutaneous effects in hormonal contraception]. PubMed · 1985 · 3 citations
    29. Diffuse hair loss in women Therapeutische Umschau · 2002 · 3 citations
    30. Die kontrazeptive Betreuung androgenisierter Frauen mit einem niedrig dosierten cyproteronacetathaltigen Einphasenpräparat DMW - Deutsche Medizinische Wochenschrift · 1979 · 18 citations